This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Agios Pharmaceuticals, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of Jeffrey D. Wilson
Introduction
Jeffrey D. Wilson is an accomplished inventor based in Ipswich, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds for treating medical conditions.
Latest Patents
Wilson holds a patent for "Crystalline forms of n-(4-(4-(cyclopropylmethyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide." This patent includes amorphous and crystalline hemisulfate salt forms of the compound. Additionally, it outlines pharmaceutical compositions that utilize these forms, along with methods for their manufacture and applications for treating conditions associated with pyruvate kinase, such as pyruvate kinase deficiency.
Career Highlights
Jeffrey D. Wilson is currently associated with Agios Pharmaceuticals, Inc., where he continues to work on groundbreaking pharmaceutical innovations. His expertise in the field has led to advancements that have the potential to improve patient outcomes significantly.
Collaborations
Throughout his career, Wilson has collaborated with notable colleagues, including Jose Luis Rios Lizarraga and Eric Simone. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in the pharmaceutical industry.
Conclusion
Jeffrey D. Wilson's contributions to the field of pharmaceuticals exemplify the impact of innovation in medicine. His work continues to pave the way for new treatments and advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile